T. Rowe Price Associates’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-170,569
| Closed | -$682K | – | 2600 |
|
|
2019
Q4 | $682K | Buy |
170,569
+115,834
| +212% | +$544K | ﹤0.01% | 2048 |
|
|
2019
Q3 | $268K | Sell |
54,735
-137,721
| -72% | -$771K | ﹤0.01% | 2320 |
|
|
2019
Q2 | $1.17M | Buy |
192,456
+9,800
| +5% | +$52.1K | ﹤0.01% | 1783 |
|
|
2019
Q1 | $1.06M | Buy |
182,656
+2,000
| +1% | +$20.7K | ﹤0.01% | 1816 |
|
|
2018
Q4 | $2.43M | Buy |
180,656
+598
| +0.3% | +$10.1K | ﹤0.01% | 1514 |
|
|
2018
Q3 | $3.5M | Sell |
180,058
-214,824
| -54% | -$4.57M | ﹤0.01% | 1501 |
|
|
2018
Q2 | $10.1M | Buy |
394,882
+225,569
| +133% | +$5.26M | ﹤0.01% | 1341 |
|
|
2018
Q1 | $3.41M | Buy |
169,313
+6,525
| +4% | +$152K | ﹤0.01% | 1474 |
|
|
2017
Q4 | $3.27M | Sell |
162,788
-5,350
| -3% | -$105K | ﹤0.01% | 1485 |
|
|
2017
Q3 | $3.48M | Buy |
168,138
+20,200
| +14% | +$342K | ﹤0.01% | 1486 |
|
|
2017
Q2 | $2.19M | Sell |
147,938
-1,262,022
| -90% | -$21M | ﹤0.01% | 1537 |
|
|
2017
Q1 | $22.5M | Sell |
1,409,960
-972,959
| -41% | -$14M | ﹤0.01% | 1112 |
|
|
2016
Q4 | $30M | Sell |
2,382,919
-1,934,731
| -45% | -$36M | 0.01% | 992 |
|
|
2016
Q3 | $121M | Sell |
4,317,650
-1,256,433
| -23% | -$42.2M | 0.02% | 531 |
|
|
2016
Q2 | $195M | Sell |
5,574,083
-48,851
| -0.9% | -$1.54M | 0.04% | 416 |
|
|
2016
Q1 | $154M | Buy |
5,622,934
+446,332
| +9% | +$13.1M | 0.03% | 457 |
|
|
2015
Q4 | $177M | Buy |
5,176,602
+746,569
| +17% | +$23.3M | 0.04% | 430 |
|
|
2015
Q3 | $127M | Sell |
4,430,033
-108,268
| -2% | -$4.63M | 0.03% | 514 |
|
|
2015
Q2 | $203M | Sell |
4,538,301
-323,507
| -7% | -$12.2M | 0.04% | 443 |
|
|
2015
Q1 | $163M | Sell |
4,861,808
-93,870
| -2% | -$2.55M | 0.03% | 483 |
|
|
2014
Q4 | $132M | Buy |
+4,955,678
| New | +$120M | 0.03% | 537 |
|
Other funds holding DPLO
T. Rowe Price Associates's DPLO Position: Q1 2020 in Review
T. Rowe Price Associates sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 170,569 shares — an estimated $682K sold.
T. Rowe Price Associates first reported a position in DPLO in Q4 2014 and held it in 21 quarters. The position peaked at $203M in Q2 2015. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.
- T. Rowe Price Associates reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
- T. Rowe Price Associates sold 170,569 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $682K.
- T. Rowe Price Associates first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and held it in 21 quarters.
- T. Rowe Price Associates's DIPLOMAT PHARMACY, INC. position peaked at $203M in Q2 2015.
- 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.
Based on T. Rowe Price Associates's 13F filing for Q1 2020, filed 15 May 2020.